CCL2 and type 2 diabetes mellitus: T2DM increases the mass of visceral adipose tissue [2] and results in the secretion of various inflammatory cytokines such as interleukin (IL)‐1β, monocyte chemoattractant protein 1 (MCP‐1), and IL‐6, which trigger chronic, low‐grade inflammation [3].